Literature DB >> 25345520

Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.

H A Kelly1, K A Grant, H Gidding, K S Carville.   

Abstract

We performed an ecological study using sentinel consultation data from a medical deputising service to assess the impact of increasing coverage with childhood varicella vaccine on the incidence risk of varicella and zoster in the population served by the deputising service in Victoria, Australia from 1998 to 2012. Following a successful vaccination programme, the incidence of varicella in Australia was modelled to decrease and the incidence of zoster to increase, based on a theoretical decrease in boosting of zoster immunity following a decrease in wild varicella virus circulation due to vaccination. Incidence risks (consultation proportions for varicella and zoster) were directly age-standardised to the Melbourne population in 2000, when varicella vaccine was first available. Age-standardised varicella incidence risk peaked in 2000 and halved by 2012. Age-standardised zoster incidence risk remained constant from 1998 to 2002, but had almost doubled by 2012. The increase in zoster consultations largely reflected increases in people younger than 50 years-old. Although causality cannot be inferred from ecological studies, it is generally agreed that the decrease in varicella incidence is due to increasing varicella vaccine coverage. The possible indirect effect of the vaccine on zoster incidence is less clear and ongoing monitoring of zoster is required.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25345520     DOI: 10.2807/1560-7917.es2014.19.41.20926

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

1.  Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.

Authors:  Kristine Macartney; Heather F Gidding; Lieu Trinh; Han Wang; Aditi Dey; Brynley Hull; Karen Orr; Jocelynne McRae; Peter Richmond; Michael Gold; Nigel Crawford; Jennifer A Kynaston; Peter McIntyre; Nicholas Wood
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

2.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

3.  Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era.

Authors:  Luodan Suo; Li Lu; Qinghai Wang; Fan Yang; Xu Wang; Xinghuo Pang; Mona Marin; Chengbin Wang
Journal:  Vaccine       Date:  2017-07-03       Impact factor: 3.641

4.  Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

Authors:  Jean-Marc G Guedon; Michael B Yee; Mingdi Zhang; Stephen A K Harvey; William F Goins; Paul R Kinchington
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

5.  Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

Authors:  Ioanna D Pavlopoulou; Stavroula Poulopoulou; Christina Melexopoulou; Ioanna Papazaharia; George Zavos; Ioannis N Boletis
Journal:  BMC Infect Dis       Date:  2015-07-24       Impact factor: 3.090

6.  Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.

Authors:  Alies van Lier; Anna Lugnér; Wim Opstelten; Petra Jochemsen; Jacco Wallinga; François Schellevis; Elisabeth Sanders; Hester de Melker; Michiel van Boven
Journal:  EBioMedicine       Date:  2015-08-08       Impact factor: 8.143

Review 7.  Dissecting the indirect effects caused by vaccines into the basic elements.

Authors:  Carla D Scarbrough Lefebvre; Augustin Terlinden; Baudouin Standaert
Journal:  Hum Vaccin Immunother       Date:  2015-07-17       Impact factor: 3.452

8.  Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study.

Authors:  Shin-Yi Tsai; Cheng-Li Lin; Ying-Chi Wong; Tse-Yen Yang; Chien-Feng Kuo; Jiung-Mou Cheng; Jyh-Seng Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 9.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

10.  Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study.

Authors:  You Jeong Kim; Chang Nam Lee; Mi So Lee; Ji Hyun Lee; Jun Young Lee; Kyungdo Han; Young Min Park
Journal:  J Korean Med Sci       Date:  2018-12-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.